Nonclinical Safety, Pharmacokinetics, and Pharmacodynamics of Atacicept-Reference-Cited by-同舟云学术

Nonclinical Safety, Pharmacokinetics, and Pharmacodynamics of Atacicept

Published:2008-06-02 Issue:1 Volume:105 Page:200-210
ISSN:1096-6080
Container-title:Toxicological Sciences
language:en
Short-container-title:

Author:

Carbonatto Michela,Yu Ping,Bertolino Mauro,Vigna Enrico,Steidler Stephanie,Fava Laura,Daghero Chiara,Roattino Bruno,Onidi Manuela,Ardizzone Michele,Peano Sergio,Visich Jennifer,Janszen Derek,Dillon Stacey,Ponce Rafael

Publisher

Oxford University Press (OUP)

Subject

Toxicology

Link

http://academic.oup.com/toxsci/article-pdf/105/1/200/16678988/kfn105.pdf

Reference43 articles.

1. Enforced bcl-xL gene expression restored splenic B lymphocyte development in BAFF-R mutant mice;J. Immunol.,2003

2. Phase I clinical study of atacicept in patients with relapsed and refractory B-cell non-Hodgkin's lymphoma;Clin. Cancer Res.,2008

3. BLyS–an essential survival factor for B cells: Basic biology, links to pathology and therapeutic target;Autoimmun. Rev.,2004

4. Analysis of time relations of electrocardiogram;Heart,1920

5. Cutting edge: The dependence of plasma cells and independence of memory B cells on BAFF and APRIL;J. Immunol.,2008

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Povetacicept, an Enhanced Dual APRIL/BAFF Antagonist That Modulates B Lymphocytes and Pathogenic Autoantibodies for the Treatment of Lupus and Other B Cell–Related Autoimmune Diseases;Arthritis & Rheumatology;2023-04-19

2. Novel treatment strategies for acetylcholine receptor antibody-positive myasthenia gravis and related disorders;Autoimmunity Reviews;2022-07

3. Telitacicept, a novel humanized, recombinant TACI-Fc fusion protein, for the treatment of systemic lupus erythematosus;Drugs of Today;2022

4. Hspa13 Promotes Plasma Cell Production and Antibody Secretion;Frontiers in Immunology;2020-05-29

5. Gm6377 suppressed SP 2/0 xenograft tumor by down-regulating Myc transcription;Clinical and Translational Oncology;2020-01-16